Cargando…
WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
WW domain binding protein-2 (WBP2) can function as a Yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ) co-activator and has a crucial role in promoting breast cancer progression. However, the expression and potential molecular mechanisms of WBP2 in the context of l...
Autores principales: | Han, Qiang, Rong, Xuezhu, Lin, Xuyong, Zhang, Xiupeng, Fan, Chuifeng, Zhao, Huanyu, Wang, Enhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035140/ https://www.ncbi.nlm.nih.gov/pubmed/33837178 http://dx.doi.org/10.1038/s41419-021-03600-3 |
Ejemplares similares
-
WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018) -
FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells
por: Rong, Xuezhu, et al.
Publicado: (2019) -
WWC Proteins: Important Regulators of Hippo Signaling in Cancer
por: Höffken, Verena, et al.
Publicado: (2021) -
The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer
por: Zheng, Xiaoying, et al.
Publicado: (2017) -
Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
por: Lim, Yvonne Xinyi, et al.
Publicado: (2021)